Enhanc3d Genomics

BiotechnologySeries ACambridge, UKenhancedgenomics.com

Latest round

Series A

Last raised

Sep 2025

Total raised

$23M

Investors

5

About Enhanc3d Genomics

Based in Cambridge, UK, and incorporated in 2020, Enhanc3d Genomics Ltd operates as a biotechnology research platform that uses machine learning to discover and develop biological diseases. The company works on a new application to improve human healthcare. It uses machine learning to enhance the potential of 3D genomics by linking genes enhancers and non-coding genetic variants. The technology used by the firm includes artificial intelligence driver functional modeling, whole-genome 3D structure mapping, GenLink 3D Platform, etc. Enhanc3d Genomics Ltd earns revenue by licensing validated drug targets, partnering with pharma for discovery programs, and developing proprietary therapeutics using its 3D multi-omics platform.

Who invested in Enhanc3d Genomics

5 investors across 3 rounds

See all investors in Enhanc3d Genomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 16, 2025

    Amount

    $8.3M

    Investors

    Locked

  2. Series A

    Aug 25, 2022

    Amount

    $12M

    Investors

    Locked

  3. Seed

    Mar 26, 2021

    Amount

    $2.4M

    Investors

    Locked

Questions about Enhanc3d Genomics

Who invested in Enhanc3d Genomics?

Enhanc3d Genomics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Enhanc3d Genomics raised?

Enhanc3d Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Enhanc3d Genomics last raise money?

Enhanc3d Genomics's most recent round on record is a Series A, in Sep 2025.

What does Enhanc3d Genomics do?

Based in Cambridge, UK, and incorporated in 2020, Enhanc3d Genomics Ltd operates as a biotechnology research platform that uses machine learning to discover and develop biological diseases.

Where is Enhanc3d Genomics headquartered?

Enhanc3d Genomics is headquartered in Cambridge, UK.

Which VCs invest in companies like Enhanc3d Genomics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Enhanc3d Genomics's stage. Their profiles are linked below.

Raising like Enhanc3d Genomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.